Lawmakers Say That Legalization in Connecticut Is Dead for This Year

April 22, 2016
AggregatedNews
Connecticut, Policy & Legal
0 Comments

Connecticut lawmakers have been saying for months that a bill to legalize marijuana had no chance of approval during an election year, and the bill has now been withdrawn.

Rep. Juan Candelaria, a New Haven Democrat who was the measure’s chief proponent, brought out an amendment for recreational use Wednesday night on a related bill, but he then withdrew it.

During a speech on the floor of the House of Representatives, Candelaria said that Connecticut should join the trend of legalization in places like Alaska, Colorado and Washington, D.C.

“By not taking action, we have failed our voters,” Candelaria said. “Connecticut should follow in their footsteps. … We have a mechanism to balance this budget, and we refuse to use it.”

He added, “Maybe this may not be the year. … Legalization is my wish, but my wish may not be granted today.” [Read more at the Hartford Courant]

This Post Has 0 Comments

Recent Stories

Recreational marijuana backers try to overcome rocky history in South Dakota

Advocates of legalizing recreational marijuana in South Dakota, a mission with a rocky history, submitted thousands of signatures to election officials on Tuesday in the hopes of once again getting…

C3 Industries’ Brotherly Model for MSO Success

Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…

Why Falling THC Test Results Matter

By Aaron Pelley, Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…

What would marijuana reclassification mean in Wisconsin?

The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…